VirexpR announced that it has raised investment in an equity round of funding from new investor, Groupe Tera SA on April 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 EUR | 0.00% | -1.53% | +1.58% |
Apr. 29 | Groupe Tera SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 18 | Oregon reconsiders drug decriminalization | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.58% | 14.75M | |
+16.97% | 84.24B | |
+12.99% | 58.82B | |
+21.40% | 24.87B | |
+29.47% | 11.79B | |
+23.35% | 11.59B | |
-4.81% | 6.61B | |
+23.13% | 4.84B | |
+20.33% | 4.78B | |
-6.92% | 2.98B |
- Stock Market
- Equities
- ALGTR Stock
- News Groupe TERA
- VirexpR announced that it has received funding from Groupe Tera SA